Eupraxia Pharmaceuticals Inc. (EPRX) stock forecast and price target
Price $8.15 · data as of November 13, 2026
12-month price target
Average target$16.71
Upside / downside+105.0%
Analysts12
ConsensusStrong buy
Low $14.00Average $16.71High $25.00
Gold marker: average target · white marker: today’s price ($8.15)
Analyst ratings
Strong buy 1Buy 12Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.96 | +6.8% | $0 |
| Next fiscal year ends December 31, 2027 | $-1.04 | −7.9% | $712580 |
| Next quarter ends December 31, 2026 | $-0.26 | +30.6% | $0 |
| Quarter after ends December 31, 2026 | $-0.26 | +29.2% | $0 |
Consensus of the analysts covering Eupraxia Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Frequently asked questions
What is the Eupraxia Pharmaceuticals stock price target?
The average 12-month target from 12 analysts is $16.71, 105.0% above the current price of $8.15 Targets range from $14.00 to $25.00.
Is Eupraxia Pharmaceuticals a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 12 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Eupraxia Pharmaceuticals expected to earn?
Analysts expect EPS of $-0.96 for the fiscal year ending December 31, 2026 and $-1.04 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.